跳至主要内容
临床试验/NCT02358733
NCT02358733终止不适用

Use of Intra-Cytoplasmic Morphologically Selected Sperm Injection (IMSI) in Poor Responders to In Vitro Fertilization (IVF): a Prospective, Double-blind, Randomized, Controlled Trial

Centro de Infertilidad y Reproducción Humana2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2015年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
10
试验地点
2
主要终点
Clinical pregnancy rate

研究概览

简要总结

This is a pilot study which aims to determine the role of IMSI in poor responders.

详细描述

This is a pilot study which aims to determine the role of IMSI over ICSI in poor responders to IVF, without a background of teratozoospermia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
37 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • poor ovarian response

排除标准

  • body mass index (BMI) ≥ 30 kg/m2
  • presence of endocrinopathies (e.g., diabetes, hyperprolactinemia, hypothyroidism)
  • altered karyotype or documented genetic defects in one or both partners
  • history of chronic, autoimmune or metabolic diseases
  • altered meiosis in testicular biopsy or altered sperm-FISH
  • teratozoospermia
  • participation, simultaneously or within the previous 6 months, in another clinical trial with medication

研究组 & 干预措施

Treatment

Experimental

Intra-cytoplasmic Morphologically-selected Sperm Injection (IMSI)

干预措施: Intra-cytoplasmic Morphologically-selected Sperm Injection (Procedure)

Control

Active Comparator

Intracytoplasmic sperm injection (ICSI)

干预措施: Intra-cytoplasmic Sperm Injection (Procedure)

结局指标

主要结局

Clinical pregnancy rate

时间窗: Four to six weeks after embryo transfer

Percentage of patients presenting with presence of an intrauterine gestational sac with embryonic cardiac activity display, evaluated by ultrasound, per cycle initiated

次要结局

  • Number of embryos obtained(Two days after egg retrieval)
  • Percentage of cycles with embryo transfer(Two days after egg retrieval)

研究者

发起方
Centro de Infertilidad y Reproducción Humana
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验